{"status": "OK", "response": {"docs": [{"type_of_material": "Article", "blog": [], "news_desk": null, "lead_paragraph": "The great steel-and-glass structures of our hospitals, medical centers and research institutes--the new cathedrals of industrialized society--rear up on our urban skylines from Stockholm to Wichita, and in the developing world as well.", "headline": {"main": "Medical Nemesis; The 20th-century's leading Luddite turns to medicine"}, "abstract": "revd by H Jack Geiger; illus", "print_page": "BR1", "word_count": 1972, "_id": "4fc49a6c45c1498b0da87b9e", "snippet": "The great steel-and-glass structures of our hospitals, medical centers and research institutes--the new cathedrals of industrialized society--rear up on our urban skylines from Stockholm to Wichita, and in the developing world as well.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/abstract.html?res=9E0DE5DC1439EE35A25751C0A9639C946790D6CF", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "MEDICAL NEMESIS. THE EXPROPRIATION OF HEALTH"}, {"name": "persons", "value": "ILLICH, IVAN"}, {"name": "subject", "value": "BOOK REVIEWS"}], "byline": {"person": [{"firstname": "H.", "middlename": "Jack", "lastname": "GEIGER", "rank": 1, "role": "reported", "organization": ""}], "original": "By H. JACK GEIGER"}, "document_type": "article", "pub_date": "1976-05-02T00:00:00Z", "section_name": null}, {"type_of_material": "Article", "blog": [], "news_desk": null, "lead_paragraph": "A few weeks ago it seemed that nobody had anything good to say about the drug stocks.", "headline": {"main": "INVESTING; The Drug Stocks Bounce Back First Period Profits Top Predictions of Analysts"}, "abstract": "Drug stocks, depressed by comparatively poor earnings reptd for 4th qr and for all '75, gain nearly 4% since Mar; various factors cited; profit increases cited for Merck & Co, Upjohn, Bristol-Myers and Johnson & Johnson; table of drug makers, listed in order of sales, with estimated and actual earnings per share and recent stock price; illus (M)", "print_page": "F5", "word_count": 1160, "_id": "4fc495b945c1498b0da7422f", "snippet": "A few weeks ago it seemed that nobody had anything  good to say about the drug stocks.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/abstract.html?res=9E00E6D91F30E135A25751C0A9639C946790D6CF", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "DRUGS AND DRUG TRADE"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Steven", "rank": 1, "lastname": "RATTNER"}], "original": "By STEVEN RATTNER"}, "document_type": "article", "pub_date": "1976-05-02T00:00:00Z", "section_name": null}], "meta": {"hits": 2, "offset": 0, "time": 53}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}